A Phase I Trial of Indoximod and Temozolomide-Based Therapy for Children With Progressive Primary Brain Tumors
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2018
At a glance
- Drugs Indoximod (Primary) ; Temozolomide (Primary) ; Cyclophosphamide; Etoposide
- Indications Brain cancer; Ependymoma; Glioma; Medulloblastoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors NewLink Genetics Corporation
- 01 Mar 2018 According to a New Links Genetics Corporation media release, data will be presented at AACR Annual Meeting 2018.
- 22 Jan 2018 Planned End Date changed from 1 Jul 2018 to 1 Dec 2019.
- 22 Jan 2018 Planned primary completion date changed from 1 Jul 2017 to 1 Mar 2019.